title: Olanzapine-induced agranulocytosis.
abstract: The antipsychotic drug olanzapine was developed to reduce the risk of haematotoxicity. We report a case of agranulocytosis induced by olanzapine.
authors.forename: R
authors.initials: R
authors.lastname: Naumann
authors.forename: W
authors.initials: W
authors.lastname: Felber
authors.forename: H
authors.initials: H
authors.lastname: Heilemann
authors.forename: T
authors.initials: T
authors.lastname: Reuster
mesh_terms: D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines; D006801:Humans; D008297:Male; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine